Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 25, 2015 4:23 PM ET

Diversified Consumer Services

Company Overview of King's College London

Company Overview

King's College London is an educational institution. The institution is based in London, United Kingdom. King's College London is part of University Of London.

Strand Street

London,  WC2R 2LS

United Kingdom


44 20 7836 5454

Key Executives for King's College London

Dean of Chapel
Age: 60
Director of the National Nursing Research Unit
Compensation as of Fiscal Year 2015.

King's College London Key Developments

King's College London Presents at ARM's 3rd Annual EU Advanced Therapies Investor Day 2015, Nov-12-2015 02:15 PM

King's College London Presents at ARM's 3rd Annual EU Advanced Therapies Investor Day 2015, Nov-12-2015 02:15 PM. Venue: Royal Institute of British Architects, 66 Portland Place, London W1B 1AD, United Kingdom. Speakers: Michael Linden, Ph.D., Professor of Virology.

Auris Medical Holding AG Announces Drug Discovery Collaboration with King's College London

Auris Medical Holding AG announced a drug discovery collaboration with King's College London, UK. Professor David E. Thurston of the Institute of Pharmaceutical Science will lead a team at King's to develop and optimize a range of specific small molecules for Auris Medical's AM-102 project. The AM-102 compounds bind to a novel, undisclosed drug target for treating certain types of tinnitus. The collaboration project draws on earlier work performed for Auris Medical by the Wolfson Centre for Age-Related Diseases at King's under the leadership of Professor Patrick Doherty and Dr. Gareth Williams. From the research project Auris Medical aims to select a lead compound for further preclinical and subsequent clinical development. The drug target for AM-102 was identified and validated previously through a collaboration with another leading research institution. It is different from the drug target for AM-101, Auris Medical's late-stage investigational tinnitus treatment. Tinnitus, the perception of sound without external acoustic stimulation, is a symptom common to various ear or other diseases. Inner ear tinnitus may be provoked by various injuries to the cochlea, the organ of hearing, such as overexposure to noise or inflammation. It may be short and just transitory; however, it may also become permanent. Tinnitus of less than three months of duration is considered acute, while older tinnitus is considered chronic. Inner ear tinnitus may be only a slight nuisance, but often it has a serious impact on the ability to sleep, relax, or concentrate, or it may lead to tiredness, irritation, nervousness, despair, frustration, or even depression.

King's College London Presents at 25th IPD/IPF Property Investment Conference, Nov-19-2015 10:15 AM

King's College London Presents at 25th IPD/IPF Property Investment Conference, Nov-19-2015 10:15 AM. Venue: The Grand Hotel, 97-99 King's Road, Brighton, East Sussex BN1 2FW, United Kingdom. Speakers: Nick Butler, Visiting Professor.

Similar Private Companies By Industry

Company Name Region
Chapters Hair Design Limited Europe
Bright Sparks Childcare Europe
Capcon Surveillance Bureau Ltd. Europe
Metropix VR Ltd. Europe
Apollo Holdco Limited Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Kings College London, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at